Hillevax Inc(NASDAQ:HLVX) 
HilleVax, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing novel vaccines. The company is headquartered in Boston, Massachusetts.
Website: https://www.hillevax.com/
Founded: 2020
IPO Price: $17 (Apr 29, 2022)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-03-20
P
O 1.74
H 1.77
L 1.71
C 1.72
V 65,849
10EMA 1.72
20EMA 1.72
60EMA 1.72
120EMA 1.72
250EMA 1.72